Articles

Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia

Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark; Foundation for the Finnish Cancer Institute, Helsinki
Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki
Hematology Research Unit, University of Helsinki, Helsinki
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki
Department of Medicine, Kuopio University Hospital, Kuopio
Department of Medicine, Kuopio University Hospital, Kuopio
Department of Medicine, Oulu University Hospital, Oulu, Finland; Department of Hematology, University of Oulu, Oulu
Department of Internal Medicine, Tampere University Hospital, Tampere
Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Department of Clinical Hematology, Turku University Hospital, Turku
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki
Hematology Research Unit, University of Helsinki, Helsinki
Department of Clinical Chemistry, University of Helsinki and Helsinki University Hospital
Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; Hematology Research Unit, University of Helsinki, Helsinki
Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki
Department of Clinical Hematology, Turku University Hospital, Turku
Department of Medicine, Kuopio University Hospital, Kuopio
Department of Internal Medicine, Tampere University Hospital, Tampere
Department of Medicine, Oulu University Hospital, Oulu
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland; Foundation for the Finnish Cancer Institute, Helsinki, Finland; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Vol. 108 No. 7 (2023): July, 2023 https://doi.org/10.3324/haematol.2022.281692